This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: National Health Research Institutes. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Kun-Hung Lee: Innovator in Kinase Inhibitors
Introduction
Kun-Hung Lee is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of heterocyclic compounds for therapeutic uses. His work focuses on innovative solutions to treat various medical conditions.
Latest Patents
Kun-Hung Lee holds a patent for "Heterocyclic compounds as kinase inhibitors for therapeutic uses." This patent includes heterocyclic compounds of a specific formula and pharmaceutical compositions containing these compounds. Additionally, it discloses a method for treating conditions modulated by the colony-stimulating factor-1 receptor using these heterocyclic compounds. He has 1 patent to his name.
Career Highlights
Kun-Hung Lee is affiliated with the National Health Research Institutes, where he conducts research aimed at improving health outcomes through innovative drug development. His work is characterized by a commitment to advancing medical science and enhancing therapeutic options for patients.
Collaborations
He collaborates with various professionals in his field, including his coworker Wen-Hsing Lin, to further his research and development efforts.
Conclusion
Kun-Hung Lee's contributions to the field of kinase inhibitors exemplify the impact of innovative research in pharmaceuticals. His work continues to pave the way for new therapeutic approaches.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile